Ann: Medgate extends European ResAppDx trial, page-8

By keeping it as a trial they don’t need to pay for it - how much are they charging patients?

At what point do we say enough is enough and at least make a commitment - ie subject to further improvements will purchase and this is the price

I think we will get screwed on price because they know we are new to the game

It is the next Telehealth providers that I am interested in - this is where the money will be made AIMO